Category: Markets

The Nifty index has been on a strong uptrend in the past three weeks, but it has recently retraced some of those gains. It is now expected to oscillate within the 19,605 to 19,878 range over the next few sessions. Three stocks that look good for buying over the next 2-3 weeks are Havells India, KSB, and Gujarat Ambuja Exports. All three stocks have strong bullish momentum and are trading above their key moving averages.

Maruti Suzuki stock gains on bullish stance from global brokerages Shares of Maruti Suzuki India surged on Friday after global brokerages Citi and Morgan Stanley maintained bullish stance on the counter. Both brokerages cited the company's improving product mix and attractive valuation as key reasons for their optimism. In addition, Maruti Suzuki reported strong sales performance in August 2023, with total domestic sales jumping 14 percent year-on-year and sale of utility vehicles jumping 118 percent year-on-year. Overall, the bullish stance from global brokerages and the company's strong sales performance are providing a boost to Maruti Suzuki stock.

Shares of PNB Gilts hit upper circuit on September 22, 2023, following news that India's inclusion in JPMorgan's bond index is seen driving billions of dollars of inflows. The index provider will add Indian bonds to its widely-tracked emerging market index starting June 28, 2024. PNB Gilts is a primary dealer in government securities and other fixed-income instruments. The inclusion of Indian bonds in JPMorgan's index is expected to attract significant foreign inflows, which is likely to benefit PNB Gilts and other primary dealers in government securities.

Indian bond markets are expected to remain stable in the near term after JPMorgan's inclusion of India in its widely tracked emerging market debt index, according to BlackRock's head of Asia Pacific fixed income, Neeraj Seth. Seth expects inflows of around $20 billion to $25 billion into India after the maximum weight threshold is achieved on the GBI-EM index. Given the size of the global government bond market, this is relatively small and is unlikely to have a significant impact on volatility.

Indian benchmark indices Sensex and Nifty fell for the fourth consecutive day on September 22, despite the inclusion of Indian bonds in the JP Morgan Government Bond Index-Emerging Markets (GBI-EM) global index suite from June 2024. The market is expected to remain volatile in the near term, with key support at 19,600 for Nifty.

The Indian rupee appreciated against the US dollar on Friday, as the inclusion of India in the JPMorgan bond index boosted investor sentiment. The rupee settled 19 paise higher at 82.94 (provisional) against the previous close. Analysts expect India’s inclusion in the bond index will lead to a direct inflow of USD 20-25 billion in the debt over the 18-21 months. However, the impact of the announcement may not be sustainable amid a rally in the greenback and foreign fund outflows from domestic equities.

The pharmaceutical sector is experiencing bearish sentiment on September 22, with profit-booking pressure and short positions in several individual stocks, including Glenmark, Cipla, Alkem, and Dr Reddy's. Analysts believe that the Nifty Pharma Index could see further weakness if it breaks below the 14700-14800 support zone. On the other hand, Aurobindo Pharma is seen as a moderately bullish stock, with strong resistance at the 900 strike price and strong support at the 850 and 860 strike prices. Traders should be cautious and monitor the market closely for any further developments.

Apollo Tyres shares fell over 2 percent on September 21 after the company announced a temporary halt of its bias off-the-road (OTR) tyre production at its Limda plant in Gujarat due to concerns from shop floor employees. The company said it is in discussions with labour union representatives to address their concerns and find a resolution. The situation is not expected to have a material impact on Apollo Tyres' operations.

Shares of Themis Medicare, a smallcap pharma company, surged to a lifetime high on Thursday after the company fixed a record date for a stock split. The stock has surged 33% so far this year, as against a 10% gain in the S&P BSE Sensex. Themis Medicare specializes in the manufacture of a wide range of products for pain management, critical care, and anti-infectives. The company has a portfolio of over 30 products and is present in 17 states.

Indian stock markets fell for the third consecutive day on September 21, tracking weak global cues. The US Federal Reserve maintained the status quo in its policy meeting but indicated that interest rates will remain higher for longer. This led to selling by foreign institutional investors (FII) and elevated crude oil prices remained a concern. Broader market performed even worse than the benchmark indices. All sectoral indices, barring Nifty Media, closed in the red. Nifty PSU Bank was the biggest loser during the day, falling 2.28 percent. Analysts believe that the market may remain volatile in the near term due to factors such as the hawkish stance by the US Fed, rising oil prices and erratic rainfall. However, they advise investors to stay stock-specific with a focus on risk management.